Physician profile
Luca Giordano
NPI 1407049604
$8,154.66
in general payments reported to CMS, 2019-2025
20 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $404 · 2021: $619 · 2022: $345 · 2023: $3,158 · 2024: $2,876 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,414 · Food and Beverage: $2,889 · Gift: $24.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,414.48 |
| Food and Beverage | $2,888.58 |
| Gift | $24.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,042.51 | 2019-2024 | Da Vinci Surgical System |
| Ethicon US, LLC | $807.06 | 2019-2022 | |
| Baxter Healthcare | $593.98 | 2021-2025 | Tisseel, Perclot |
| W. L. Gore & Associates, INC. | $371.65 | 2021-2025 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Covidien LP | $276.57 | 2019-2020 | |
| Teleflex LLC | $241.82 | 2023 | Titan Sgs Standard Gastric Stapler |
| Medtronic, INC. | $178.91 | 2024-2025 | Transorb |
| Reshape Lifesciences INC. | $121.38 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $92.32 | 2021-2025 | Gattex |
| Davol INC. | $70.55 | 2021-2023 | Arista Ah Flexitip, Phasix Mesh |
| Conmed Corporation | $60.96 | 2024 | Airseal |
| Braintree Laboratories, INC. | $50.82 | 2021 | |
| Nestle Healthcare Nutrition INC. | $49.28 | 2023 | |
| Smith+Nephew, INC. | $45.60 | 2019-2024 | Collagenase Santyl |
| Shire North American Group INC | $43.81 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $32.40 | 2025 | Zenpep |
| Seagen INC. | $25.62 | 2019 | |
| Kci USA, INC. | $23.04 | 2023 | Prevena, V.A.C. Dermatac |
| Lilly USA, LLC | $13.62 | 2019 | |
| Foundation Medicine, INC. | $12.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luca Giordano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.